Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2003

View Archived Issues

Drug pipeline for rheumatoid arthritis

GSK designs novel series of glucocorticoids

Akzo Nobel researchers identify new analgesic ORL1 receptor modulators

Inhibitors of HCV RNA replication discovered at Roche

Novel HIV RT inhibitors prepared and tested at Roche

U. of Michigan claims dopamine receptor modulators for cocaine abuse and other disorders

Gabapentin and pregabalin prodrugs designed by XenoPort scientists

Novel glutamate receptor potentiators identified by Lilly research team

Vertex patent covers novel p38 kinase inhibitors

Onyx discontinues development of ONYX-015 to focus on Bay-43-9006

Canvaxin receives fast track designation for metastatic melanoma

Triapine enters further phase II trial in prostate cancer

FM-VP4 safe and well tolerated in phase I study

Elixir signs agreement with UCSF for aging-related research

Discerna joint venture updates progress

First treatment for acute ischemic stroke cleared for use in Europe

Canadian launch announced for the new coxib Bextra

FDA advisory committee to review Vitrase NDA

Genaera focuses development efforts

Magnesium sulfate superior to nimodipine for preventing eclampsia

Improved cardiovascular safety profile found for nesiritide vs. dobutamine in decompensated CHF

T-588 prevents retinal ganglion cell death in rats with elevated IOP

Increase in synaptic density in the brain of aged rats following treatment with FK-960

Kissei presents potent and selective beta3-adrenoceptor agonists for bladder dysfunction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...